Search

Displaying results 2381 - 2390 of 4188 in total
  1. Drug

    Ramucirumab

    go.drugbank.com/drugs/DB05578
    ApprovedInvestigational

    Ramucirumab is a human monoclonal antibody (IgG1) against vascular endothelial growth factor receptor 2 (VEGFR2), a type II trans-membrane tyrosine kinase receptor expressed on endothelial cells. By binding to VEGFR2, ramucirumab prevent...

  2. Drug

    ISIS 14803

    go.drugbank.com/drugs/DB05803
    Investigational

    ISIS 14803 is a 20-unit antisense phosphorothioate oligodeoxynucleotide that binds to hepatitis C virus (HCV) RNA at the translation initiation region of the internal ribosome entry site (IRES) and inhibits protein expression in cell cul...

  3. Drug

    Tucidinostat

    go.drugbank.com/drugs/DB06334
    Investigational

  4. Drug

    Gisadenafil

    go.drugbank.com/drugs/DB11902
    Investigational

    Gisadenafil has been investigated for the treatment of Prostatic Hyperplasia.

  5. Drug

    Napabucasin

    go.drugbank.com/drugs/DB12155
    Investigational

    Napabucasin has been investigated for the treatment of Colorectal Carcinoma.

  6. Drug

    Puerarin

    go.drugbank.com/drugs/DB12290
    Investigational

    Puerarin has been investigated for the treatment of Alcohol Abuse.

  7. Drug

    Piclozotan

    go.drugbank.com/drugs/DB12361
    Investigational

    Piclozotan has been investigated for the treatment of Parkinson's Disease.

  8. Drug

    Glyceryl Trierucate

    go.drugbank.com/drugs/DB12528
    Investigational

    Glyceryl Trierucate has been investigated for the treatment of Adrenoleukodystrophy.

  9. Drug

    AZD-7295

    go.drugbank.com/drugs/DB12724
    Investigational

    AZD7295 has been investigated for the treatment of Hepatitis C.

  10. Drug

    Glyceryl Trioleate

    go.drugbank.com/drugs/DB13038
    Investigational

    Glyceryl Trioleate has been investigated for the treatment of Adrenoleukodystrophy.